Immix Biopharma, Inc. 4

Immix Biopharma CEO and Chairman Ilya M. Rachman received an option award for 500,000 shares of common stock at $8.78 per share.

On May 22, 2026, Immix Biopharma, Inc. CEO and Chairman Ilya M. Rachman was granted a stock option to purchase 500,000 shares of common stock at an exercise price of $8.78 per share, with the option vesting in 48 equal monthly installments over four years, contingent on continued service. The Form 4 indicates this new option award and corresponding underlying common stock equivalent, resulting in post-transaction derivative holdings of 500,000 option shares, which represent an estimated notional value of approximately $4.39 million at the stated exercise price. This appears to be a significant equity-based compensation grant rather than an open-market purchase or sale.

Filing Facts

CIK

1873835

Ticker

IMMX

Form

4

Source Type

sec

Accession

0001493152-26-026425

Alert Tier

7